WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Thank you for another great WorkBoat Show! We hope to see everyone back in New Orleans December 2–4, 2026. Save the date!

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

339.98 -0.61 (-0.18%)
Official Closing Price Updated: 1:10 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
The Ultimate Guide To Stock Investing Success ↗
A discussion about how you can really identify stocks that you can add to your portfolio that will be winners in the long run. 
Via Talk Markets
Topics Stocks / Equities
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Humana Earnings On Deck: Investors Brace For Slower Growth Clip ↗
Humana to release Q4 2024 earnings on Feb. 11 before market hours. Previous quarter saw 15.2% revenue increase, EPS beat but missed guidance. 
Via Benzinga
News headline image
Humana (HUM) Q4 Earnings: What To Expect
Health insurance company Humana (NYSE:HUM) will be reporting results tomorrow before market hours. Here’s what to expect. 
Via StockStory
News headline image
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below. 
Via Chartmill
News headline image
Earnings Scheduled For February 5, 2025 ↗
 
Via Benzinga
News headline image
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Breaking Down Cencora: 6 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move ↗
Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an... 
Via Benzinga
News headline image
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
News headline image
Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines ↗
Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and FY25 guidance was raised. 
Via Benzinga
News headline image
Cencora (NYSE:COR) Reports Upbeat Q4
Healthcare distributor Cencora (NYSE:COR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 12.8% year on year to $81.49 billion. Its non-GAAP profit of $3.73 per... 
Via StockStory
News headline image
Cencora Reports Fiscal 2025 First Quarter Results
From Cencora
Via Business Wire
News headline image
Looking Into Cencora's Recent Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday? ↗
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data. 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
(COR) - Analyzing Cencora's Short Interest ↗
 
Via Benzinga
News headline image
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Looking Into Cencora's Recent Short Interest ↗
 
Via Benzinga
News headline image
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower ↗
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60. 
Via Benzinga
News headline image
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Completes Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
News headline image
Cencora Closes $1.8 Billion Senior Notes Offering
From Cencora
Via Business Wire
News headline image
McKesson Stock Gets A RS Rating Lift To 75 ↗
The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75. 
Via Investor's Business Daily
News headline image
Cardinal Health Stock Sees IBD RS Rating Improve To 71 ↗
In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday. 
Via Investor's Business Daily
News headline image
Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
From Cencora
Via Business Wire
News headline image
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday? ↗
An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner. 
Via Benzinga
Topics Government
News headline image
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings ↗
Cencora will potentially pay up to $500 million in aggregate contingent consideration in fiscal years 2027 and 2028. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2025 Diversified Communications. All rights reserved.